Larvol Delta - Subretinal-Gene-Therapy-Drug-AGTC501-for-XLinked-Retinitis-Pigmentosa-XLRP-Phase-12-Multicenter-Study-Horizon-24Month-Interim-Results

AGTC-501 - AGTC

https://www.xcdsystem.com/maculasociety/program/myvkUIM/index.cfm?pgid=358&RunRemoveSessionFilter=1

Andreas Lauer, MD

Jan 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next